Terms: = Bone cancer AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR
44 results:
1. Revealing the pharmacological effects of Remodelin against osteosarcoma based on network pharmacology, acRIP-seq and experimental validation.
Gao J; Xu P; Wang F; Zhang W; Min M; Urba R; Fan L
Sci Rep; 2024 Feb; 14(1):3577. PubMed ID: 38347067
[TBL] [Abstract] [Full Text] [Related]
2. Superficial acral calcified chondroid mesenchymal neoplasm harboring an FN1::fgfr2 fusion and review of the literature.
Machado I; Damaskou V; Ioannidis E; Jour G; Linos K
J Cutan Pathol; 2024 May; 51(5):338-344. PubMed ID: 38328983
[TBL] [Abstract] [Full Text] [Related]
3. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
4. Chondrosarcoma with Target-Like Chondrocytes: Update on Molecular Profiling and Specific Morphological Features.
Povýšil C; Hojný J; Kaňa M
Folia Biol (Praha); 2022; 68(3):112-124. PubMed ID: 36689318
[TBL] [Abstract] [Full Text] [Related]
5. Blockade of FGF2/fgfr2 partially overcomes bone marrow mesenchymal stromal cells mediated progression of T-cell acute lymphoblastic leukaemia.
Tian C; Li Y; Wang L; Si J; Zheng Y; Kang J; Wang Y; You MJ; Zheng G
Cell Death Dis; 2022 Nov; 13(11):922. PubMed ID: 36333298
[TBL] [Abstract] [Full Text] [Related]
6. Integrated DNA Copy Number and Expression Profiling Identifies IGF1R as a Prognostic Biomarker in Pediatric Osteosarcoma.
Taylor AM; Sun JM; Yu A; Voicu H; Shen J; Barkauskas DA; Triche TJ; Gastier-Foster JM; Man TK; Lau CC
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887382
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population.
Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Xu B
BMC Cancer; 2021 Dec; 21(1):1330. PubMed ID: 34906122
[TBL] [Abstract] [Full Text] [Related]
8. Activation of fgfr2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy.
Lei JH; Lee MH; Miao K; Huang Z; Yao Z; Zhang A; Xu J; Zhao M; Huang Z; Zhang X; Chen S; Jiaying NG; Feng Y; Xing F; Chen P; Sun H; Chen Q; Xiang T; Chen L; Xu X; Deng CX
Adv Sci (Weinh); 2021 Nov; 8(21):e2100974. PubMed ID: 34514747
[TBL] [Abstract] [Full Text] [Related]
9. ETV4 and ETV5 drive synovial sarcoma through cell cycle and DUX4 embryonic pathway control.
DeSalvo J; Ban Y; Li L; Sun X; Jiang Z; Kerr DA; Khanlari M; Boulina M; Capecchi MR; Partanen JM; Chen L; Kondo T; Ornitz DM; Trent JC; Eid JE
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 33983905
[TBL] [Abstract] [Full Text] [Related]
10. Poor prognosis of male triple-positive breast cancer patients: a propensity score matched SEER analysis and molecular portraits.
Wang B; Wang H; Zhao A; Zhang M; Yang J
BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
[TBL] [Abstract] [Full Text] [Related]
11. Investigation of anticancer activities of STA-9090 (ganetespib) as a second generation HSP90 inhibitor in Saos-2 osteosarcoma cells.
Özgür A
J Chemother; 2021 Dec; 33(8):554-563. PubMed ID: 33794753
[TBL] [Abstract] [Full Text] [Related]
12. Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for bone Metastases in Patients With cancer.
Van Poznak CH; Unger JM; Darke AK; Moinpour C; Bagramian RA; Schubert MM; Hansen LK; Floyd JD; Dakhil SR; Lew DL; Wade JL; Fisch MJ; Henry NL; Hershman DL; Gralow J
JAMA Oncol; 2021 Feb; 7(2):246-254. PubMed ID: 33331905
[TBL] [Abstract] [Full Text] [Related]
13. Receptor Tyrosine Kinases in Osteosarcoma: 2019 Update.
Greenfield EM; Collier CD; Getty PJ
Adv Exp Med Biol; 2020; 1258():141-155. PubMed ID: 32767239
[TBL] [Abstract] [Full Text] [Related]
14. Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement.
Amary F; Perez-Casanova L; Ye H; Cottone L; Strobl AC; Cool P; Miranda E; Berisha F; Aston W; Rocha M; O'Donnell P; Pillay N; Tirabosco R; Baumhoer D; Hookway ES; Flanagan AM
Mod Pathol; 2019 Dec; 32(12):1762-1771. PubMed ID: 31273315
[TBL] [Abstract] [Full Text] [Related]
15. Nuclear Fibroblast Growth Factor Receptor Signaling in Skeletal Development and Disease.
Tuzon CT; Rigueur D; Merrill AE
Curr Osteoporos Rep; 2019 Jun; 17(3):138-146. PubMed ID: 30982184
[TBL] [Abstract] [Full Text] [Related]
16. Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemia.
Jerchel IS; Hoogkamer AQ; Ariës IM; Boer JM; Besselink NJM; Koudijs MJ; Pieters R; den Boer ML
Sci Rep; 2019 Feb; 9(1):1875. PubMed ID: 30755670
[TBL] [Abstract] [Full Text] [Related]
17. Establishment of a New Scirrhous Gastric cancer Cell Line with fgfr2 Overexpression, OCUM-14.
Okuno T; Yashiro M; Masuda G; Togano S; Kuroda K; Miki Y; Hirakawa K; Ohsawa M; Wanibuchi H; Ohira M
Ann Surg Oncol; 2019 Apr; 26(4):1093-1102. PubMed ID: 30652228
[TBL] [Abstract] [Full Text] [Related]
18. Single cell sequencing reveals gene expression signatures associated with bone marrow stromal cell subpopulations and time in culture.
Liu S; Stroncek DF; Zhao Y; Chen V; Shi R; Chen J; Ren J; Liu H; Bae HJ; Highfill SL; Jin P
J Transl Med; 2019 Jan; 17(1):23. PubMed ID: 30635013
[TBL] [Abstract] [Full Text] [Related]
19. Overexpression of
Lee KKL; Peskett E; Quinn CM; Aiello R; Adeeva L; Moulding DA; Stanier P; Pauws E
Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30266836
[TBL] [Abstract] [Full Text] [Related]
20. The Mutational Profile of Unicystic Ameloblastoma.
Heikinheimo K; Huhtala JM; Thiel A; Kurppa KJ; Heikinheimo H; Kovac M; Kragelund C; Warfvinge G; Dawson H; Elenius K; Ristimäki A; Baumhoer D; Morgan PR
J Dent Res; 2019 Jan; 98(1):54-60. PubMed ID: 30216733
[TBL] [Abstract] [Full Text] [Related]
[Next]
